Taufon eye drops 40 mg/ml bottle 5 ml 3 pcs

• dystrophic lesions of the cornea and retina, including hereditary tapetoretinal degenerations;
• cataracts (age-related, diabetic, traumatic, radiation);
• as a means of stimulating reparative processes in corneal injuries;
• open-angle glaucoma (as an additional remedy).

• active ingredient: taurine;
• 1 ml of solution contains 40 mg of taurine;
• Excipients: methyl parahydroxybenzoate (nipagin) (E 218), purified water.

Hypersensitivity to taurine or to other components of the drug.

Some patients may develop allergic reactions, conjunctival hyperemia, itching, burning, and stinging in the eyes.

The drug is prescribed to adults. Immediately before use, it is advisable to hold the bottle with the drug in the palm of your hand to warm it to body temperature.

For the treatment of cataracts, prescribe 2-3 drops 2-4 times a day every day. Duration of treatment is 3 months. Repeat the course with an interval of 1 month.

For injuries, apply 2-3 drops 2-4 times a day for 1 month.

For the treatment of tapetoretinal degeneration and other degenerative diseases of the retina, penetrating corneal injuries, the drug is administered under the conjunctiva at a dose of 0.3 ml of a 4% solution once a day for 10 days. The course of treatment is repeated after 6-8 months.

In open-angle glaucoma, the drug is instilled 2-3 drops into the conjunctival sac 2 times a day 20-30 minutes before using timolol. The course of treatment is determined by the doctor individually.

In open-angle glaucoma, the drug should be used in combination with timolol 20-30 minutes before instillation of timolol.

Use during pregnancy or breastfeeding

The efficacy and safety of the drug during pregnancy or breastfeeding have not been studied.

Children

The efficacy and safety of the drug in children have not been studied.

Ability to influence reaction speed when driving vehicles or other mechanisms

The effect of the drug on the human body while driving or working with other mechanisms has not been studied.

As with other topical ophthalmic drugs, temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs during instillation, the patient should wait until vision clears before driving or operating machinery.

Cases of overdose have not been described.

Interaction with other medicinal products and other types of interactions

When used simultaneously with timolol eye drops, a potentiated decrease in intraocular and arterial pressure is observed.

When simultaneously prescribing several drugs for topical application to the eye, they should be administered at intervals of 10-15 minutes. Eye ointments should be applied last.

Store at a temperature not exceeding 25 °C in the original packaging.

Keep out of reach of children.